title: Regarding "Infliximab in the Treatment of Refractory Ocular Inflammatory Diseases" by Kam et al.
authors.affiliation: C-MER (Shenzhen) Dennis Lam Eye Hospital Shenzhen, China.
authors.forename: Shirley
authors.initials: S
authors.lastname: Liu
authors.forename: Connie H
authors.initials: CH
authors.lastname: Cao
authors.forename: Amy Y
authors.initials: AY
authors.lastname: Yu
authors.forename: Sophy C
authors.initials: SC
authors.lastname: Zhang
authors.forename: Lucy L
authors.initials: LL
authors.lastname: Zhu
mesh_terms: D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D003320:Corneal Ulcer / Q000188:drug therapy*; D005260:Female; D006801:Humans; D000069285:Infliximab / Q000627:therapeutic use*; D007634:Keratitis / Q000188:drug therapy*; D008297:Male; D014605:Uveitis / Q000188:drug therapy*
chemical_list: D000893:Anti-Inflammatory Agents; D000069285:Infliximab